Vicapsys Life Sciences, Inc.
VICP
$1.50
-$0.27-15.25%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 89.60K | -- | -- | 9.40K | 53.50K |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | 30.20K | 52.30K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | 102.70K |
| Total Current Assets | 89.60K | -- | -- | 39.70K | 208.50K |
|
|
|||||
| Total Current Assets | 89.60K | -- | -- | 39.70K | 208.50K |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 89.60K | -- | -- | 39.70K | 208.50K |
|
|
|||||
| Total Accounts Payable | 1.24M | 1.14M | 1.06M | 970.70K | 894.70K |
| Total Accrued Expenses | 916.30K | 839.00K | 736.50K | 643.80K | 340.40K |
| Short-term Debt | 578.90K | 461.90K | 462.30K | 353.90K | 307.30K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 2.74M | 2.45M | 2.26M | 1.97M | 1.54M |
|
|
|||||
| Total Current Liabilities | 2.74M | 2.45M | 2.26M | 1.97M | 1.54M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 578.90K | 461.90K | 462.30K | 353.90K | 307.30K |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 2.74M | 2.45M | 2.26M | 1.97M | 1.54M |
|
|
|||||
| Common Stock & APIC | 14.41M | 14.37M | 14.37M | 14.37M | 14.37M |
| Retained Earnings | -17.05M | -16.82M | -16.63M | -16.30M | -15.70M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -2.65M | -2.45M | -2.26M | -1.93M | -1.33M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -2.65M | -2.45M | -2.26M | -1.93M | -1.33M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -2.65M | -2.45M | -2.26M | -1.93M | -1.33M |
|
|
|||||